Literature DB >> 18362881

MicroRNAs accurately identify cancer tissue origin.

Nitzan Rosenfeld1, Ranit Aharonov, Eti Meiri, Shai Rosenwald, Yael Spector, Merav Zepeniuk, Hila Benjamin, Norberto Shabes, Sarit Tabak, Asaf Levy, Danit Lebanony, Yaron Goren, Erez Silberschein, Nurit Targan, Alex Ben-Ari, Shlomit Gilad, Netta Sion-Vardy, Ana Tobar, Meora Feinmesser, Oleg Kharenko, Ofer Nativ, Dvora Nass, Marina Perelman, Ady Yosepovich, Bruria Shalmon, Sylvie Polak-Charcon, Eddie Fridman, Amir Avniel, Isaac Bentwich, Zvi Bentwich, Dalia Cohen, Ayelet Chajut, Iris Barshack.   

Abstract

MicroRNAs (miRNAs) belong to a class of noncoding, regulatory RNAs that is involved in oncogenesis and shows remarkable tissue specificity. Their potential for tumor classification suggests they may be used in identifying the tissue in which cancers of unknown primary origin arose, a major clinical problem. We measured miRNA expression levels in 400 paraffin-embedded and fresh-frozen samples from 22 different tumor tissues and metastases. We used miRNA microarray data of 253 samples to construct a transparent classifier based on 48 miRNAs. Two-thirds of samples were classified with high confidence, with accuracy >90%. In an independent blinded test-set of 83 samples, overall high-confidence accuracy reached 89%. Classification accuracy reached 100% for most tissue classes, including 131 metastatic samples. We further validated the utility of the miRNA biomarkers by quantitative RT-PCR using 65 additional blinded test samples. Our findings demonstrate the effectiveness of miRNAs as biomarkers for tracing the tissue of origin of cancers of unknown primary origin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362881     DOI: 10.1038/nbt1392

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  377 in total

1.  MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.

Authors:  Muhua Yang; Yuan Yao; Gabriel Eades; Yongshu Zhang; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2011-06-03       Impact factor: 4.872

2.  MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.

Authors:  Manuela Ferracin; Massimo Pedriali; Angelo Veronese; Barbara Zagatti; Roberta Gafà; Eros Magri; Maria Lunardi; Gardenia Munerato; Giulia Querzoli; Iva Maestri; Linda Ulazzi; Italo Nenci; Carlo M Croce; Giovanni Lanza; Patrizia Querzoli; Massimo Negrini
Journal:  J Pathol       Date:  2011-06-01       Impact factor: 7.996

3.  Accurate classification of metastatic brain tumors using a novel microRNA-based test.

Authors:  Wolf C Mueller; Yael Spector; Tina Bocker Edmonston; Brianna St Cyr; Diana Jaeger; Ulrike Lass; Ranit Aharonov; Shai Rosenwald; Ayelet Chajut
Journal:  Oncologist       Date:  2011-01-27

4.  High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.

Authors:  Xiao-Guang Liu; Wang-Yu Zhu; Yan-Yan Huang; Li-Na Ma; Shi-Quan Zhou; Ye-Kai Wang; Fang Zeng; Ji-Hang Zhou; Yong-Kui Zhang
Journal:  Med Oncol       Date:  2011-04-24       Impact factor: 3.064

Review 5.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

6.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

Review 7.  MicroRNAs: novel biomarkers for gastrointestinal carcinomas.

Authors:  Li Xie; Xiaoping Qian; Baorui Liu
Journal:  Mol Cell Biochem       Date:  2010-04-27       Impact factor: 3.396

8.  miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression.

Authors:  S Bhattacharjya; S Nath; J Ghose; G P Maiti; N Biswas; S Bandyopadhyay; C K Panda; N P Bhattacharyya; S Roychoudhury
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

9.  [Structured diagnostics and therapy of the CUP syndrome].

Authors:  H Löffler; K Neben; A Krämer
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

10.  [Cancer of unknown primary. Epidemiology and pathogenesis].

Authors:  H Löffler; K Neben; A Krämer
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.